Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.11, moving +1.63% from the previous trading session. The stock's performance was ahead of the S&P 500's daily gain of 0.11%.

The software-as-a-service (SaaS) sell-off or SaaS-pocalypse, as it’s commonly referred to, has been a major story this year.

How doors, keys, and backtracking unlocked survival horror.

Examines how AI agent delegation enables risks like session smuggling and escalation, with defenses such as scoped ...

CoinDesk Research maps five crypto privacy approaches and examines which models hold up as AI improves. Full coverage of ...

While millennials dissect every feeling in £80 therapy sessions, their grandparents built the exact same coping mechanisms ...

Relying on one giant AI model for everything is a trap; it’s too expensive and slow for simple tasks and too risky for the ...

In Trend’s view, art is love’s lasting archive, turning fleeting desire into a form that endures long after the heart that ...

The United States has developed and deployed Artificial Intelligence on the battlefield, but there's one enormous leap in the ...